Singapore opens synthetic biology lab to grab share of global market set to grow to $80b in 2030

SINGAPORE – A new laboratory has been launched in Singapore to transform recent breakthroughs in synthetic biology into commercial products from eco-friendly cosmetics to affordable vaccines.

At the heart of the new lab’s mission is the use of bioengineered yeast and fungi as “cell factories” to convert simple nutrients into complex molecules for the production of everything, from vaccines to biofuels.